Stockhub

Celcuity Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

19 August 2022

12 August 2022

27 July 2022

  • curprev 11:2711:27, 27 July 2022‎ Chris talk contribs‎ 1,001 bytes +1,001‎ Created page with "Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mam..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/Celcuity_Inc.’